Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-PhotoVaporization 120W versus transurethral resection of the prostate

Benejam-Gual, J.M.; Sanz-Granda, Á; Grávalos, R. García-Miralles; Velasco, A. Severa-Ruíz de; Pons-Viver, J.

doi:10.1016/j.acuroe.2014.02.007

Actas Urológicas Españolas (English Edition)

2014

DOI: 10.1016/j.acuroe.2014.02.007

|View full text |Cite

Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-PhotoVaporization 120W versus transurethral resection of the prostate

J.M. Benejam-Gual

Á Sanz-Granda²,

R. García-Miralles Grávalos

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

2023

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room

Gill

Ulchaker

2018

Curr Urol Rep

View full text Add to dashboard Cite

The American Urological Association released updated guidelines in 2018 for the surgical management of BPH. Over recent years, analyses investigating the cost-effectiveness of the modalities included in these guidelines have been completed. These show relatively newer, minimally-invasive office-based therapies can provide cost-effective alternatives to medical therapy. Likewise, surgical therapies provide a cost-effective means of BPH management, if performed well with low complication rates. However, comparisons of these studies are limited by the biases they contain. Minimally-invasive office-based therapies and well performed surgical therapies for BPH can achieve cost equivalence to combination medical therapy within a few years. Factors such as age, gland size, patient compliance, and surgeon skill should be considered when personalizing treatment recommendations for each patient.

show abstract

Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room

Gill

Ulchaker

2018

Curr Urol Rep

View full text Add to dashboard Cite

show abstract

Cost Comparison of Benign Prostatic Hyperplasia Treatment Options

2019

View full text Add to dashboard Cite

Adenomectomía laparoscópica extraperitoneal «sin nudos»

García-Segui

Verges

Galán-Llopis

et al. 2015

Actas Urológicas Españolas

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-PhotoVaporization 120W versus transurethral resection of the prostate

Cited by 5 publications

References 14 publications

Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room

Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room

Cost Comparison of Benign Prostatic Hyperplasia Treatment Options

Adenomectomía laparoscópica extraperitoneal «sin nudos»

Contact Info

Product

Resources

About